Evidence map›Paper›PMID 36907559›Full record

ArticleVirus research2023

Broad-host-range lytic Erwinia phage Key with exopolysaccharide degrading activity.

Maryna Zlatohurska, Tetiana Gorb, Liudmyla Romaniuk, Natalia Shenderovska, Yuliia Faidiuk, Ganna Zhuminska, Yuliia Hubar, Oleksandr Hubar, Andrew M Kropinski, Alla Kushkina and 1 more

Open access · goldAbstract read
In one paragraph

Article in Virus research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Frontiers in plant science · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Maryna ZlatohurskaDepartment of Bacteriophage Molecular Genetics, D. K. Zabolotny Institute of Microbiology and Virology, the National Academy of Sciences (NAS) of Ukraine, Kyiv 03143, Ukraine.
Tetiana GorbDepartment of Bacteriophage Molecular Genetics, D. K. Zabolotny Institute of Microbiology and Virology, the National Academy of Sciences (NAS) of Ukraine, Kyiv 03143, Ukraine.
Liudmyla RomaniukDepartment of Bacteriophage Molecular Genetics, D. K. Zabolotny Institute of Microbiology and Virology, the National Academy of Sciences (NAS) of Ukraine, Kyiv 03143, Ukraine.
Natalia ShenderovskaDepartment of Bacteriophage Molecular Genetics, D. K. Zabolotny Institute of Microbiology and Virology, the National Academy of Sciences (NAS) of Ukraine, Kyiv 03143, Ukraine; Biotechnology products development lab, Scientific Center, Pharmaceutical Corporation YURiA-PHARM, Kyiv 03151, Ukraine.
Yuliia FaidiukDepartment of Bacteriophage Molecular Genetics, D. K. Zabolotny Institute of Microbiology and Virology, the National Academy of Sciences (NAS) of Ukraine, Kyiv 03143, Ukraine; Educational and Scientific Center "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv 01601, Ukraine; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw 53-114, Poland.
Ganna ZhuminskaDepartment of Microbiology, Virology and Biotechnology, Biological Faculty, Odesa National Mechnykov University, Odesa 65058, Ukraine.
Yuliia HubarPreclinical and Clinical Trials Department, Pharmaceutical Corporation YURiA-PHARM, Kyiv 03151, Ukraine.
Oleksandr HubarBiotechnology products development lab, Scientific Center, Pharmaceutical Corporation YURiA-PHARM, Kyiv 03151, Ukraine.
Andrew M KropinskiDepartments of Food Science; and, Pathobiology, University of Guelph, Guelph, ON N1G 2W1, Canada.
Alla KushkinaDepartment of Bacteriophage Molecular Genetics, D. K. Zabolotny Institute of Microbiology and Virology, the National Academy of Sciences (NAS) of Ukraine, Kyiv 03143, Ukraine.
Fedor TovkachDepartment of Bacteriophage Molecular Genetics, D. K. Zabolotny Institute of Microbiology and Virology, the National Academy of Sciences (NAS) of Ukraine, Kyiv 03143, Ukraine.
Danylo Zabolotny Institute of Microbiology and Virology · UANational University Odesa Law Academy · UATaras Shevchenko National University of Kyiv · UAUniversity of Guelph · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, the genome of the lytic broad-host-range phage Key infecting Erwinia amylovora, Erwinia horticola, and Pantoea agglomerans strains was characterized. Key phage has a 115,651 bp long double-stranded DNA genome with the G + C ratio of 39.03%, encoding 182 proteins and 27 tRNA genes. The majority (69%) of predicted coding sequences (CDSs) encode proteins with unknown functions. The protein products of 57 annotated genes were found to have probable functions in nucleotide metabolism, DNA replication, recombination, repair, and packaging, virion morphogenesis, phage-host interaction and lysis. Furthermore, the product of gene 141 shared amino acid sequence similarity and conserved domain architecture with the exopolysaccharide (EPS) degrading proteins of Erwinia and Pantoea infecting phages as well as bacterial EPS biosynthesis proteins. Due to the genome synteny and similarity to the proteins of T5-related phages, phage Key, together with its closest relative, Pantoea phage AAS21, was suggested to represent a novel genus within the Demerecviridae family, for which we tentatively propose the name "Keyvirus".

Indexed as

BacteriophagesErwinia amylovoraGenome, ViralHost SpecificityVirionBiocontrolErwinia amylovoraExopolysaccharide depolymeraseFire blightT5-related phages

Identifiers

PMID36907559
PMCPMC10194208
OpenAlexW4324020403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.